Patents expiring in 2028

US 7329681

Inhibitors of IMPDH enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7329721

Maleamic acid polymer derivatives and their bioconjugates

Nektar Therapeutics AL, Corporation · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7329511

Nucleic acid encoding GAD65

The Regents of the University of California · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7329672

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7329752

Carbamate compounds as 5-HT4 receptor agonists

Theravance, Inc. · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7329502

ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7329651

Cannabimimetic ligands

UNIVERSITY OF CONNECTICUT · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7329638

Drug delivery compositions

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7332612

Amorphous and crystalline forms of losartan potassium and process for their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7332590

Molecular characteristics of non-small cell lung cancer

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7332585

Bispecific single chain Fv antibody molecules and methods of use thereof

The Regents of the California University · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7332527

Cross-linked ionic core micelles

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7332484

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7332602

Pyridyl substituted heterocycles useful for treating or preventing HCV infection

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7332472

Cyclosporine analogue mixtures and their use as immunomodulating agents

Isotechnika, Inc. · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7332470

Methods and compositions for treating ocular disease

The Regents of the University of California · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7332321

Viral fibers

The Board of Regents of the University of Texas System · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7332298

Nucleic acids encoding multimeric proteins of TNF superfamily ligands

The Regents of the University of California · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7332287

Methods and compositions for diagnosing breast cancer

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7332281

Therapeutic targets in cancer

Sagres Discovery, Inc. · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7332469

Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions

The Board of Regents of the University of Texas System · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7332172

Transformed bacteria producing CS6 antigens as vaccines

The United States of America as represented by the Secretary of the Army · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7332170

Classical swine fever virus virulence determinant and a novel classical swine fever vaccine

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7331920

Glycopeptide antibiotics, combinational libraries of glycopeptide antibiotics and methods of producing same

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7332224

Cleaning article containing hydrophilic polymers

ReGenesis Group · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7332471

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7332645

IL-21 as a regulator of immunoglobin production

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7332159

Method and composition for inhibiting reperfusion injury in the brain

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7335640

Administration of hypocretin-1 for treatment of narcolepsy

The Regents of the University of California · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7335799

Hydroxyl compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7335356

Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein

The United States of America as represented by the Secretary of the Army · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7335744

Prostate cancer specific internalizing human antibodies

The Regents of the California University · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7335772

1H-imidazo [4,5-c] quinolin-4-cyano and 1H-imidazo [4,5-c] quinolin-4-carboxamide intermediates

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7335773

Intermediates for imidazonaphthyridines

Graceway Pharmaceuticals. LLC · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7335749

Tumor suppressor gene, p47Ing3

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7335662

Substituted tricyclic compounds as protein kinase inhibitors

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7335685

Crystals of ladostigil tartrate, methods of production and pharmaceutical compositions thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7335689

Dihydroxyl compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7335681

Amino ceramide-like compounds and therapeutic methods of use

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7335382

Compositions and methods for the treatment and prevention of cancer

Northwestern University · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7335658

Pyridazine derivatives and their use as therapeutic agents

Xenon Pharmaceuticals Inc. · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7335679

Wortmannin analogs and methods of using same

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7335646

Compositions and methods for regulated protein expression in gut

ENGENE, INC. · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7335499

tRNA synthetase

Replidyne, Inc. · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7335477

Truncated recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines

United States of America as represented by the Secretary of the Air Force · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7335383

Generation of nitric oxide in vivo from nitrite, nitrate or nitrosothiols endogenous in blood

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7338807

Screening assays for compounds that cause apoptosis

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7338961

Sphingosine kinase inhibitors

Apogee Biotechnology Corporation · Granted Tue Mar 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)